Midgut Neuroendocrine Tumor — Trials

Midgut Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

6 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03667092	Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor(GENEBIOLuNET)	completed	N/A	47	University Hospital, ToulouseOTHER	1	Apr 10, 2025	clinicaltrials
NCT02651987	Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg(CLARINET FORTE)	completed	Phase 2	99	IpsenINDUSTRY	10	Oct 3, 2022	clinicaltrials
NCT02358356	Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study(CONTROL NETS)	completed	Phase 2	75	Australasian Gastro-Intestinal Trials GroupNETWORK	1	Jul 5, 2022	clinicaltrials

Data updated 22 days agoSource updated Apr 10, 2025source: clinicaltrials